Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomised, Phase I, Study to Determine the Effect of Food on the Pharmacokinetics of Single Oral Doses of AZD9291 in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI

NCT02163733 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02163733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02163733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomised, Phase I, Study to Determine the Effect of Food on the Pharmacokinetics of Single Oral Doses of AZD9291 in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
November 14, 2014
Completion date
January 24, 2023
Enrollment
38 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

advanced (inoperable) non small cell lung cancer, advanced non small cell lung cancer